Currently, the available studies provide an opportunity to summarize the potential of MSCs and their secretomes in experimental models of insulin-resistant PCOS and to gain a better understanding of how treatment-related factors influence insulin-resistant PCOS outcomes. Here, INS is linked to polycystic ovary syndrome.